AGIO Agios Pharmaceuticals, Inc.
AGIO Agios Pharmaceuticals, Inc.
Healthcare · Biotechnology
Desk view
Market read
POC $27.69 · VWAP $30.62 · +20.8% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
2 watchlists
AGIO Price Structure
Loading timeframes…
Peers
Every watchlist AGIO belongs to, members best 30-day change first — AGIO highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@biotech-capital-cycle
Reported the quarter ending 2026-06-30: revenue $45M, diluted EPS -$1.69, net income -$101M (SEC filing, revenue corroborated by the desk's provider cache). Across the print the stock moved -14.3% (close before → first close after).
full note →Against street estimates
How AGIO's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
Recent news
Headlines about AGIO from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 3 days ago · Oct 20
- Agios Pharmaceuticals (AGIO) Stock Price & Overview
- Agios Pharmaceuticals, Inc. $AGIO Holdings Raised by Assenagon Asset Management S.A. - American Market News
- Agios: AGIO Stock Price Quote & News | Robinhood
- AGIO Financials: Income Statement, Balance Sheet & Cash Flow | Agios Pharmaceuticals Inc
- AGIO Stock Quote Price and Forecast | CNN
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
AGIO research tape
4 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.